Growth Metrics

Regenerex Pharma (RGPX) Net Cash Flow (2010 - 2025)

Regenerex Pharma (RGPX) reported Net Cash Flow of -$121853.0 for Q3 2025, down 41546.6% year-over-year from N/an in Q3 2024, and up 74.65% on a QoQ basis from -$480595.0 in Q2 2025.

Regenerex Pharma (RGPX) has 14 years of Net Cash Flow data on file, last reported at -$121853.0 in Q3 2025.

  • Quarterly Net Cash Flow fell 41546.6% year-over-year to -$121853.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $51511.0 (up 990.27% YoY) and the FY2025 annual result came in at $652653.0, up 85637.75% from the prior year.
  • Net Cash Flow advanced to -$121853.0 in Q3 2025 per RGPX's latest filing, from -$480595.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $653915.0 in Q1 2025 and bottomed at -$480595.0 in Q2 2025.
  • The 5-year median for Net Cash Flow is -$12.0 (2023), against an average of $3189.5.
  • Peak annual rise in Net Cash Flow reached 8837.51% in 2025, while the deepest fall reached 129092.2% in 2025.
  • Tracing RGPX's Net Cash Flow over 5 years: stood at $244.0 in 2021, then soared by 708.2% to $1972.0 in 2022, then slipped by 9.94% to $1776.0 in 2023, then slumped by 97.52% to $44.0 in 2024, then sank by 277038.64% to -$121853.0 in 2025.
  • Per Business Quant, the three latest RGPX Net Cash Flow figures stand at -$121853.0 (Q3 2025), -$480595.0 (Q2 2025), and $653915.0 (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -121,853.00
Sep 30, 2025 -121,853.00
Jun 30, 2025 -480,595.00
Jun 30, 2025 -480,595.00
Mar 31, 2025 653,915.00
Mar 31, 2025 653,915.00
Dec 31, 2024 44.00
Dec 31, 2024 44.00
Sep 30, 2024 294.00
Sep 30, 2024 294.00
Jun 30, 2024 -372.00
Jun 30, 2024 -372.00
Mar 31, 2024 -7,484.00
Mar 31, 2024 -7,484.00
Dec 31, 2023 1,776.00
Dec 31, 2023 1,776.00
Sep 30, 2023 -61,674.00
Sep 30, 2023 -61,674.00
Jun 30, 2023 66,619.00
Jun 30, 2023 66,619.00
Mar 31, 2023 -68.00
Mar 31, 2023 -68.00
Dec 31, 2022 1,972.00
Dec 31, 2022 1,972.00
Sep 30, 2022 -1,043.00
Sep 30, 2022 -1,043.00
Jun 30, 2022 -968.00
Jun 30, 2022 -968.00
Mar 31, 2022 5,361.00
Mar 31, 2022 5,361.00
Dec 31, 2021 244.00
Dec 31, 2021 244.00
Sep 30, 2021 -3,084.00
Sep 30, 2021 -3,084.00
Jun 30, 2021 4,327.00
Jun 30, 2021 4,327.00
Dec 31, 2020 -2,367.00
Dec 31, 2020 -2,367.00
Sep 30, 2020 772.00
Sep 30, 2020 772.00
Jun 30, 2020 -2,144.00
Jun 30, 2020 -2,144.00
Mar 31, 2020 -433,597.00
Mar 31, 2020 -433,597.00
Dec 31, 2019 134,502.00
Dec 31, 2019 134,502.00
Sep 30, 2019 137,045.00
Sep 30, 2019 137,045.00
Jun 30, 2019 84,964.00
Jun 30, 2019 84,964.00
Mar 31, 2019 103,539.00
Mar 31, 2019 103,539.00
Dec 31, 2018 75,794.00
Dec 31, 2018 75,794.00
Sep 30, 2018 381.00
Sep 30, 2018 381.00
Jun 30, 2018 1,222.00
Jun 30, 2018 1,222.00
Mar 31, 2018 14,543.00
Mar 31, 2018 14,543.00
Dec 31, 2017 15,663.00
Dec 31, 2017 15,663.00
Sep 30, 2017 9,560.00
Sep 30, 2017 9,560.00
Jun 30, 2017 34,206.00
Jun 30, 2017 34,206.00
Mar 31, 2017 676.00
Mar 31, 2017 676.00
Nov 30, 2014 -10,241.00
Nov 30, 2014 -10,241.00
Aug 31, 2014 9,877.00
Aug 31, 2014 9,877.00
May 31, 2014 815.00
May 31, 2014 815.00
Feb 28, 2014 711.00
Feb 28, 2014 711.00
Nov 30, 2013 -5,114.00
Nov 30, 2013 -5,114.00
Aug 31, 2013 4,902.00
Aug 31, 2013 4,902.00
May 31, 2013 -4,411.00
May 31, 2013 -4,411.00
Feb 28, 2013 -4,136.00
Feb 28, 2013 -4,136.00
Nov 30, 2012 13,594.00
Nov 30, 2012 13,594.00
Aug 31, 2012 1,943.00
Aug 31, 2012 1,943.00
May 31, 2012 -4,005.00
May 31, 2012 -4,005.00
Feb 29, 2012 5,482.00
Feb 29, 2012 5,482.00
Nov 30, 2011 67,182.00
Nov 30, 2011 67,182.00
Aug 31, 2011 -3,505.00
Aug 31, 2011 -3,505.00
Nov 30, 2010 13,000.00
Nov 30, 2010 13,000.00